An analysis of 10 years' records for 67,000 patients in Finland found that, compared with treatment with the first-generation drug perphenazine, the risk of early death for patients on clozapine was reduced by 26 percent.
By contrast, mortality risk was 41 percent higher for those on Seroquel, known chemically as quetiapine; 34 percent higher with Johnson & Johnson's Risperdal, or resperidone; and 13 percent higher with Eli Lilly's Zyprexa, or olanzapine.
1 comment:
Ironic given that the atypicals were developed as safer alternatives to really-effective-but-might-kill-you-with-agranulocytosis clozapine...
Post a Comment